OncLive

?? Tomorrow is the FINAL and most exciting day of the 42nd Annual CFS! Listen in as Yan Leyfman, MD, of MedNews Week, shares what he is most excited for ahead of tomorrow! #CFS24 ???? Learn more about the event at https://lnkd.in/e9648sEf

Hear Joseph M. Scandura, MD, PhD, of?Weill Cornell Medicine discuss the phase 2 SENTRY-2 study evaluating single-agent selinexor in JAK inhibitor–naive #myelofibrosis. Watch more here: https://lnkd.in/gDGJ-Ayy

This Thanksgiving, we are deeply grateful for our outstanding Editorial Board. Your expertise in oncology and invaluable feedback have played a crucial role in guiding our initiatives across various media and events. Your unwavering dedication to advancing cancer care inspires our mission, and we are truly thankful for your continued support. Explore our editorial board of oncology experts here: https://ow.ly/9LCT50UfjNW #OncLive #EditorialBoard #OncologyCare

Join us for an engaging webinar: Updates in CRC: Applying Evidence to Clinical Practice. Featuring: Yelena Y. Janjigian, MD & Ryan B. Corcoran, MD #CRC #OncologyWebinar #ClinicalPractice Register: https://ow.ly/p2ks50UfnLk

Watch the on-demand presentation, Leading the Way: Approaches in Biomarker Testing, Forming the Oncology Committee, to learn the benefits of forming an oncology committee that collaborates across oncology specialties and tumor types from Robert Neff, MD and Courtney Rice, MS, LCGC. https://bit.ly/4dzSoht

Tune in to hear panelists Richard Finn, MD, Olatunji Alese, MD, Daneng Li, MD, Anthony El-khoueiry, MD, Masatoshi Kudo, MD, PhD, and Steven Chan, MD, discuss the current landscape of first-line treatment for unresectable #hepatocellularcarcinoma. Click here to watch more: https://lnkd.in/gyffFgWc

Tune in to watch panelists James K. McCloskey, MD, of John Theurer Cancer Center at Hackensack University Medical Center, and?Thomas LeBlanc, MD, MA of Duke Cancer Institute discuss how myelodysplastic syndromes are diagnosed, classified, and managed, considering risk stratification tools, prognosis for lower-risk cases, and current treatment challenges. Click here for more: https://lnkd.in/gzbZpKyy

Tune in for the latest episode of #MedNewsWeek X #OncLive to hear Chandler Park, M.D., F.A.C.P. of Norton Healthcare and Stephen Liu, MD of Lombardi Comprehensive Cancer Center explore the latest treatment updates in EGFR-Mutated #NSCLC. Listen here: https://lnkd.in/gSVDVVDP

Tislelizumab plus chemotherapy has been approved in Europe for first-line advanced ESCC and gastric/GEJ adenocarcinoma. #oncology #ESCC #GEJcancer https://lnkd.in/ea-2C5RZ

This season of gratitude, let’s give thanks to the leaders in oncology who make a difference every day. Nominate a colleague or mentor for the 2025 Giants of Cancer Care? awards and help us celebrate their remarkable contributions to cancer research and care. Submit your nomination today: https://ow.ly/oyo650Ugg8C